[1] |
Sung H, Ferlay J, Siegel RL, et al.Global cancer statistics 2020:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin, 2021, 71(3): 209-249.DOI: 10.3322/caac.21660.
|
[2] |
Siegel R, Wagle NS, Cercek A, et al.Colorectal cancer statistics,2023[J].CA A Cancer J Clin, 2023, 73: 233-254.DOI: 10.3322/caac.21772.
|
[3] |
朱德祥, 任黎, 许剑民.中国结直肠癌肝转移诊断和综合治疗指南(2020版)[J].中国实用外科杂志, 2021, 41(1): 1-11.DOI: 10.19538/j.cjps.issn1005-2208.2021.01.01.Zhu DX, Ren L, Xu JM.China guideline for diagnosis and comprehensive treatment of colorectal liver metastases(2020 edition)[J].Chin J Pract Surg, 2021, 41(1): 1-11.DOI: 10.19538/j.cjps.issn1005-2208.2021.01.01.
|
[4] |
段键, 何金兰, 曾仲.结直肠癌肝转移的多学科团队治疗[J].中华消化外科杂志, 2021, 20(12): 1370-1372.DOI: 10.3760/cma.j.cn 115610-20210929-00484.Duan J, He JL, Zeng Z.Multidisciplinary treatment of colorectal liver metastasis[J].Chin J Dig Surg, 2021, 20(12): 1370-1372.DOI:10.3760/cma.j.cn115610-20210929-00484.
|
[5] |
Wisneski AD, Jin C, Huang CY, et al.Synchronous versus metachronous colorectal liver metastasis yields similar survival in modern era[J].J Surg Res, 2020, 256: 476-485.DOI: 10.1016/j.jss.2020.06.038.
|
[6] |
Ghiasloo M, Pavlenko D, Verhaeghe M, et al.Surgical treatment of stage IV colorectal cancer with synchronous liver metastases: a systematic review and network meta-analysis[J].Eur J Surg Oncol,2020, 46(7): 1203-1213.DOI: 10.1016/j.ejso.2020.02.040.
|
[7] |
王明帅, 王宏伟, 包全, 等.结直肠癌肝转移术后预后分析——单中心20年经验分享[J].中华转移性肿瘤杂志, 2024, 7(1): 10-17.DOI:10.3760/cma.j.cn101548-20231114-00116.Wang MS, Wang HW, Bao Q, et al.Postoperative prognostic analysis of colorectal liver metastasis: a single center 20-year experience sharing[J].Chin J Metastatic Cancer, 2024, 7(1): 10-17.DOI: 10.3760/cma.j.cn101548-20231114-00116.
|
[8] |
罗治文, 陈晓, 张业繁, 等.同时性结直肠癌肝转移术后早期复发的影响因素[J].中华肝胆外科杂志, 2020, 26(10): 741-747.DOI:10.3760/cma.j.cn113884-20200811-00426.Luo ZW, Chen X, Zhang YF, et al.Influencing factors of early recurrence after liver metastasis of synchronous colorectal cancer[J].Chin J Hepatobiliary Surg, 2020, 26(10): 741-747.DOI: 10.3760/cma.j.cn113884-20200811-00426.
|
[9] |
Pagani M, De Vincenti R, Cecchi C, et al.Hepatic resection in patients with colo-rectal liver metastases: surgical outcomes and prognostic factors of single-center experience[J].J Clin Med, 2023, 12(6): 2170.DOI: 10.3390/jcm12062170.
|
[10] |
Ali SM, Pawlik TM, Rodriguez-Bigas MA, et al.Timing of surgical resection for curative colorectal cancer with liver metastasis[J].Ann Surg Oncol, 2018, 25(1): 32-37.DOI: 10.1245/s10434-016-5745-7.
|
[11] |
Abelson JS, Michelassi F, Sun T, et al.Simultaneous resection for synchronous colorectal liver metastasis: the new standard of care?[J].J Gastrointest Surg, 2017, 21(6): 975-982.DOI: 10.1007/s11605-017-3422-1.
|
[12] |
Machairas N, Di Martino M, Primavesi F, et al.Simultaneous resection for colorectal cancer with synchronous liver metastases: current stateof-the-art[J].J Gastrointest Surg, 2024, 28(4): 577-586.DOI: 10.1016/j.gassur.2024.01.034.
|
[13] |
Zhou J, Feng L, Li X, et al.The value of laparoscopic simultaneous colorectal and hepatic resection for synchronous colorectal cancer liver metastasis: a propensity score matching study[J].Front Oncol,2022, 12: 916455.DOI: 10.3389/fonc.2022.916455.
|
[14] |
翟升永, 孙晓静, 钟晓东, 等.手术治疗对于同时性结直肠癌肝转移预后的影响[J].中华普通外科杂志, 2018, 33(11): 915-919.DOI:10.3760/cma.j.issn.1007-631X.2018.11.006.Zhai SY, Sun XJ, Zhong XD, et al.Effect of surgical treatment on prognosis of simultaneous liver metastasis of colorectal cancer[J].Chin J Gen Surg, 2018, 33(11): 915-919.DOI: 10.3760/cma.j.issn.1007-631X.2018.11.006.
|
[15] |
Chandra P, Sacks GD.Contemporary surgical management of colorectal liver metastases[J].Cancers, 2024, 16(5): 941.DOI: 10.3390/cancers16050941.
|
[16] |
Bolton JS, Fuhrman GM.Survival after resection of multiple bilobar hepatic metastases from colorectal carcinoma[J].Ann Surg, 2000,231(5): 743-751.DOI: 10.1097/00000658-200005000-00015.
|
[17] |
Huang L, Tang X, Fang J, et al.Synchronous colorectal liver metastases considering infectious complications: simultaneous or delayed surgery?[J].Evid Based Complement Alternat Med, 2022,2022: 5268554.DOI: 10.1155/2022/5268554.
|
[18] |
Choong K, Wong P, Thornblade L, et al.Combined liver and colon resection of synchronous colorectal liver metastases at a quaternary center[J].J Surg Res, 2023, 288: 252-260.DOI: 10.1016/j.jss.2023.03.008.
|
[19] |
Gavriilidis P, Sutcliffe RP, Hodson J, et al.Simultaneous versus delayed hepatectomy for synchronous colorectal liver metastases: a systematic review and meta-analysis[J].HPB, 2018, 20(1): 11-19.DOI: 10.1016/j.hpb.2017.08.008.
|
[20] |
Kazi M, Patkar S, Patel P, et al.Simultaneous resection of synchronous colorectal liver metastasis: Feasibility and development of a prediction model[J].Ann Hepatobiliary Pancreat Surg, 2023, 27(1): 40-48.DOI:10.14701/ahbps.22-043.
|
[21] |
Frühling P, Strömberg C, Isaksson B, et al.A comparison of the simultaneous, liver-first, and colorectal-first strategies for surgical treatment of synchronous colorectal liver metastases at two major liver-surgery institutions in Sweden[J].HPB, 2023, 25(1): 26-36.DOI: 10.1016/j.hpb.2022.09.001.
|
[22] |
Chen Q, Zhang R, Xing B, et al.Optimal surgical sequence for colorectal cancer liver metastases patients receiving colorectal cancer resection with simultaneous liver metastasis resection: a multicentre retrospective propensity score matching study[J].Int J Surg, 2022,106: 106952.DOI: 10.1016/j.ijsu.2022.106952.
|
[23] |
Wang Y, Wen N, Xiong X, et al.Timing of surgery in patients with synchronous colorectal cancer liver metastases undergoing neoadjuvant chemotherapy: a propensity score analysis[J].World J Surg Oncol, 2023, 21(1): 276.DOI: 10.1186/s12957-023-03162-y.
|
[24] |
Keck J, Gaedcke J, Ghadimi M, et al.Surgical therapy in patients with colorectal liver metastases[J].Digestion, 2022, 103(4): 245-252.DOI:10.1159/000524022.
|
[25] |
Noda T, Takahashi H, Tei M, et al.Clinical outcomes of neoadjuvant chemotherapy for resectable colorectal liver metastasis with intermediate risk of postoperative recurrence: a multi-institutional retrospective study[J].Ann Gastroenterol Surg, 2022, 7(3): 479-490.DOI: 10.1002/ags3.12631.
|
[26] |
Martin J, Petrillo A, Smyth EC, et al.Colorectal liver metastases:Current management and future perspectives[J].World J Clin Oncol,2020, 11(10): 761-808.DOI: 10.5306/wjco.v11.i10.761.
|
[27] |
Lillemoe HA, Vauthey JN.Surgical approach to synchronous colorectal liver metastases: staged, combined, or reverse strategy[J].Hepatobiliary Surg Nutr, 2020, 9(1): 25-34.DOI: 10.21037/hbsn.2019.05.14.
|
[28] |
中国医师协会外科医师分会, 中华医学会外科分会胃肠外科学组, 中华医学会外科分会结直肠外科学组, 等.中国结直肠癌肝转移诊断和综合治疗指南(2020版)[J].临床肝胆病杂志, 2021, 37(3):543-553.DOI:10.3969/j.issn.1001-5256.2021.03.009.Chinese College of Surgeons of Chinese Medical Doctor Association,Chinese Society Gastrointestinal Surgery of Chinese Society of Surgery of Chinese Medical Association, Chinese Society of Colorectal Surciety Chinese Society of Surgery of Chinese Medical Association,et al.China guideline for diagnosis and comprehensive treatment of colorectal liver metastases(2020 edition)[J].J Clin Hepatol, 2021,37(3): 543-553.DOI:10.3969/j.issn.1001-5256.2021.03.009.
|
[29] |
张炜力, 周驰, 邓宇翔, 等.初始不可切除结直肠癌肝转移转化治疗结局影响因素分析[J].中华胃肠外科杂志, 2022, 25(1): 56-62.DOI:10.3760/cma.j.cn441530-20210718-00287.Zhang WL, Zhou C, Deng YX, et al.Analysis of influencing factors on the outcome of liver metastasis and transformation therapy for initially unresectable colorectal cancer[J].Chin J Gastrointest Surg, 2022,25(1): 56-62.DOI: 10.3760/cma.j.cn441530-20210718-00287.
|
[30] |
张钰洋, 陈善稳, 王鹏远, 等.结直肠癌肝转移转化治疗的研究进展[J].中华胃肠外科杂志, 2021, 24(1): 85-93.DOI: 10.3760/cma.j.cn.441530-20200311-00135.Zhang YY, Chen SW, Wang PY, et al.Research progress of liver metastasis and transformation therapy for colorectal cancer[J].Chin J Gastrointest Surg, 2021, 24(1): 85-93.DOI: 10.3760/cma.j.cn.441530-20200311-00135.
|
[31] |
张宜利, 李巍.结直肠癌肝转移转化治疗进展[J].腹部外科, 2021,34(4): 322-326.DOI:10.3969/j.issn.1003-5591.2021.04.016.Zhang YL, Li W.Recent advances in the treatment of colorectal liver metastasis[J].J Abdom Surg, 2021, 34(4): 322-326.DOI:10.3969/j.issn.1003-5591.2021.04.016.
|
[32] |
王大强, 鞠后琼, 仲崇晗, 等.结直肠癌伴同时性不可切除肝转移转化治疗的疗效分析[J].中华普通外科杂志, 2023, 38(6): 407-411.DOI: 10.3760/cma.j.cn113855-20220817-00519.Wang DQ, Ju HQ, Zhong CH, et al.Conversion managment of colorectal cancer with simultaneous unresectable hepatic metastasis[J].Chin J Gen Surg, 2023, 38(6): 407-411.DOI: 10.3760/cma.j.cn113855-20220817-00519.
|
[33] |
Sarkar J, Attwood K, Schwarz RE.Perioperative chemotherapy is associated with superior overall survival in patients with synchronous colorectal liver metastases[J].Ann Surg Oncol, 2023, 30(13): 7986-7995.DOI: 10.1245/s10434-023-14302-9.
|
[34] |
Kawaguchi Y, Lillemoe HA, Vauthey JN.Dealing with an insufficient future liver remnant: portal vein embolization and two-stage hepatectomy[J].J Surg Oncol, 2019, 119(5): 594-603.DOI: 10.1002/jso.25430.
|
[35] |
Imai K, Allard MA, Baba H, et al.Optimal patient selection for successful two-stage hepatectomy of bilateral colorectal liver metastases[J].Ann Gastroenterol Surg, 2021, 5(5): 634-638.DOI: 10.1002/ags3.12465.
|
[36] |
Sandström P, Røsok BI, Sparrelid E, et al.ALPPS improves resectability compared with conventional two-stage hepatectomy in patients with advanced colorectal liver metastasis: results from a Scandinavian multicenter randomized controlled trial(LIGRO trial)[J].Ann Surg, 2018, 267(5): 833-840.DOI: 10.1097/SLA.0000000000002511.
|